Tag: Tuberculin
QIAGEN’s QuantiFERON-TB Gold Plus shows cost-effectiveness compared with TST in a...
QuantiFERON-TB Gold Plus reduced the modeled lifetime risk of progression to active TB among individuals with TBI by approximately 41% compared with Tuberculin Skin Test (TST)